Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:19 PM
Ignite Modification Date:
2026-03-26 @ 3:19 PM
NCT ID:
NCT07384260
Eligibility Criteria:
Inclusion criteria:
1. Aged 18-65 years, regardless of gender;
2. Planning to undertake a short-term round-trip journey to Europe (within 7 days);
3. Able to understand and willing to comply with the study protocol, and to cooperate with study procedures;
4. Voluntarily sign the informed consent form before any study-related procedures are initiated.
Exclusion criteria:
1. Diseases that may affect the evaluation of trial results, such as immune dysfunction, severe renal/hepatic dysfunction, severe cardiovascular disease, malignant tumors, acute or chronic infections, etc.;
2. Use of probiotic preparations, antibiotics, hormones, immunosuppressants, biological agents, or JAK inhibitors within 4 weeks;
3. Subjects with diagnosed or uncontrolled parasitic infections;
4. Patients receiving long-term medication for chronic diseases;
5. Patients with severe organic lesions in the thyroid, heart, brain, lungs, kidneys, or musculoskeletal system;
6. Patients with a history of or currently diagnosed mental illness;
7. Patients on long-term corticosteroid therapy;
8. Use of growth hormone, γ-aminobutyric acid (GABA), lysine, inositol, or vitamin B12;
9. Presence of uncontrolled, clinically significant laboratory abnormalities that may affect data interpretation or subject participation;
10. Participation in other clinical intervention studies involving drugs, dietary supplements, probiotics, or prebiotics within the past 4 weeks;
11. Presence of severe infections or major trauma deemed by the investigator to potentially affect outcomes, or having undergone moderate to major surgery within the past month;
12. Known allergy to any component of the probiotic product;
13. Subjects deemed unsuitable for participation by the investigator for any other reason.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT07384260
Study Brief:
Protocol Section:
NCT07384260